Developer docs
API playgroundTry for free, no card

Search company profiles

Syntegra

Full company profile

uuid0002a6i

Namestring
Syntegra
Websiteurl
syntegra.io
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Syntegra is a privately held, seed-stage company founded in 2019 and headquartered in San Francisco that applies machine learning and generative AI to produce synthetic healthcare datasets. The core product — branded "Healthcare Data Synthetic Solutions" — is a pre-trained model that generates artificial patient-level datasets mirroring the statistical properties of real-world healthcare data, enabling downstream AI training, medical research, drug discovery, medical image analysis, workflow automation, and clinical trial design without exposing sensitive patient information.

The technical approach is presented as generative AI-based synthetic data generation with an emphasis on preserving data utility for research while eliminating privacy risks. Marketing language explicitly asserts compliance with HIPAA, GDPR, and CCPA, and the company describes its differentiator as domain specialization in healthcare rather than generic synthetic-data tooling. The product was commercialized in January 2022, supported by a $5.625 million seed round led by WVV Capital in August 2020 with broad syndicate participation (Berkeley Catalyst Fund, First Spark Ventures, GRID Ventures, Hike Ventures, Impact Venture Capital, Innovation Global Capital, Launchpad Capital, Sweat Equity Ventures, Vastly Valuable Ventures, Village Global).

Commercially, Syntegra targets a single vertical — healthcare and life sciences — with pain points centered on data privacy, regulatory compliance, and limited access to real patient data for AI development. The revenue model is described as subscription or recurring, but no pricing, contract structures, ARR, or named customers are disclosed. The GTM motion is characterized as product-led with direct enterprise and partnership-led outreach to research and provider organizations, and the company is actively building collaborations across healthcare, technology, and data privacy domains. Headcount sits in the 11-50 range; leadership includes founder/CEO Michael Lesh, co-founder/CTO Ofer Mendelvitch, Head of Growth Carter Prince, and Head of Strategy and Business Operations Arthur Copstein.

Short descriptiontext

Syntegra is a San Francisco-based seed-stage company that uses generative AI to produce privacy-preserving synthetic healthcare datasets, serving healthcare and life sciences organizations for AI model training, medical research, drug discovery, and clinical trial design.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
synthetic healthcare data, healthcare AI training data, privacy-preserving datasets, synthetic data generation, healthcare data analytics
Industry2 codes
PRIMARYHDAAALAA
Synthetic Data Generation Platforms
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools
SECONDARYHDAAALAL
Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial)
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Commercial Physical & Biological Research8731
Product category
Synthetic Healthcare Data Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Synthetic Healthcare Data Solutions
TypeSubscription Recurring
Description

Commercializing synthetic healthcare data solutions for AI model training and research purposes. As a seed-stage company, the specific revenue mechanics are not yet publicly disclosed.

dlvr.it
Cost components4 values
Technology or R&D, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Syntegra applies state-of-the-art machine learning models to generate synthetic healthcare datasets that mirror the statistical properties of real-world patient data while preserving privacy and ensuring compliance with HIPAA, GDPR, and CCPA. The pre-trained synthetic data models are used for AI model training, medical research, drug discovery, and clinical trial design optimization, allowing healthcare organizations to develop and validate AI without accessing sensitive patient information.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Synthetic healthcare data enables AI model training while maintaining HIPAA/GDPR compliance
Product overview1 text field

Syntegra offers healthcare data synthetic solutions powered by generative AI. The company provides a pre-trained model that generates synthetic healthcare data for research and AI development purposes. The core product enables organizations to create privacy-compliant artificial datasets while maintaining the statistical properties of original healthcare data.

Product and service1 record
1Healthcare Data Synthetic Solutions
CategorySynthetic Data Platform
Description

AI-powered synthetic data generation platform that creates privacy-preserving artificial healthcare datasets from real-world data, enabling research and AI development without exposing sensitive patient information. Designed for healthcare organizations, life sciences companies, and research institutions that need compliant training data for AI model development, drug discovery, and clinical trial design.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Healthcare Collaborators
Strategic tierDevelopingTypeOthersAnnounced on2022-01-12
Description

Syntegra is building collaborations in healthcare, technology, and data privacy sectors. The seed funding will support growth in these collaborations, though specific named partners have not been disclosed.

dlvr.it
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

MDClone generates synthetic healthcare data for research and analytics without exposing real patient records. Direct competitor to Syntegra in the privacy-preserving healthcare synthetic data space, serving similar hospital and life sciences customers.

TypeBroad incumbent
Description

Datavant is a large, well-capitalized health data connectivity platform that has expanded into de-identified and synthetic data offerings for healthcare and life sciences. Much broader portfolio than Syntegra, but overlaps directly on enabling privacy-preserving health data access.

TypeDirect peer
Description

Gretel provides a developer-focused synthetic data platform with APIs for generating synthetic text, tabular, and time-series data, including healthcare use cases. Direct competitor on synthetic data generation technology, though Gretel is horizontal rather than healthcare-specialized.

TypeDirect peer
Description

Tonic.ai offers synthetic data generation and de-identification primarily for software development and testing, with extensions into healthcare and regulated industries. Competes with Syntegra on synthetic data tooling, though Tonic's strongest footprint is in dev/test data rather than clinical research.

TypeDirect peer
Description

Mostly AI provides a synthetic data platform for tabular data including financial services and healthcare. Direct competitor in synthetic data generation, with comparable privacy-preserving positioning to Syntegra but broader vertical reach.

TypeDirect peer
Description

Hazy is an enterprise synthetic data platform focused on financial services with expanding healthcare applications. Competes with Syntegra on generative synthetic data technology, particularly for structured tabular datasets.

TypeEmerging player
Description

Synthesis AI focuses on synthetic data for computer vision, with less direct healthcare overlap. Adjacent competitor in the broader synthetic data ecosystem relevant to AI model training.

TypeBroad incumbent
Description

AWS provides HealthLake and Bedrock-based services that include capabilities relevant to healthcare data management and synthetic data generation at scale. As a hyperscaler, AWS represents both a potential partner and a bundling threat to standalone synthetic data vendors like Syntegra.

TypeBroad incumbent
Description

IQVIA is a large CRO and healthcare data analytics provider with proprietary de-identified and synthetic patient datasets used for clinical research and commercial analytics. Competes with Syntegra at the buyer level for synthetic data in life sciences R&D.

TypeEmerging player
Description

TripleBlind offers privacy-preserving data collaboration tools for healthcare AI, including synthetic data and federated learning. Partially overlapping with Syntegra on privacy-preserving healthcare data for AI development.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Syntegra

Synthetic Healthcare Data Platformsyntegra.io

Syntegra is a San Francisco-based seed-stage company that uses generative AI to produce privacy-preserving synthetic healthcare datasets, serving healthcare and life sciences organizations for AI model training, medical research, drug discovery, and clinical trial design.

What Syntegra does

Syntegra is a privately held, seed-stage company founded in 2019 and headquartered in San Francisco that applies machine learning and generative AI to produce synthetic healthcare datasets. The core product — branded "Healthcare Data Synthetic Solutions" — is a pre-trained model that generates artificial patient-level datasets mirroring the statistical properties of real-world healthcare data, enabling downstream AI training, medical research, drug discovery, medical image analysis, workflow automation, and clinical trial design without exposing sensitive patient information.

The technical approach is presented as generative AI-based synthetic data generation with an emphasis on preserving data utility for research while eliminating privacy risks. Marketing language explicitly asserts compliance with HIPAA, GDPR, and CCPA, and the company describes its differentiator as domain specialization in healthcare rather than generic synthetic-data tooling. The product was commercialized in January 2022, supported by a $5.625 million seed round led by WVV Capital in August 2020 with broad syndicate participation (Berkeley Catalyst Fund, First Spark Ventures, GRID Ventures, Hike Ventures, Impact Venture Capital, Innovation Global Capital, Launchpad Capital, Sweat Equity Ventures, Vastly Valuable Ventures, Village Global).

Commercially, Syntegra targets a single vertical — healthcare and life sciences — with pain points centered on data privacy, regulatory compliance, and limited access to real patient data for AI development. The revenue model is described as subscription or recurring, but no pricing, contract structures, ARR, or named customers are disclosed. The GTM motion is characterized as product-led with direct enterprise and partnership-led outreach to research and provider organizations, and the company is actively building collaborations across healthcare, technology, and data privacy domains. Headcount sits in the 11-50 range; leadership includes founder/CEO Michael Lesh, co-founder/CTO Ofer Mendelvitch, Head of Growth Carter Prince, and Head of Strategy and Business Operations Arthur Copstein.

Syntegra firmographics

Firmographics
Name
Syntegra
Website
https://syntegra.io
Company type
Private
Founded year
2019
Headcount range
1–10 employees
Short description
Syntegra is a San Francisco-based seed-stage company that uses generative AI to produce privacy-preserving synthetic healthcare datasets, serving healthcare and life sciences organizations for AI model training, medical research, drug discovery, and clinical trial design.
Ownership category
akta.pro rank

Syntegra industry classification

Industry
Product category
Synthetic Healthcare Data Platform
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHDAAALAA
Synthetic Data Generation Platforms
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools
SECONDARYHDAAALAL
Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial)
Hardware, Technology & Telecom/Artificial Intelligence & Machine Learning/Synthetic Data, Data Labeling & Training Data Tools

Keywords

  • Synthetic healthcare data
  • Healthcare AI training data
  • Privacy-preserving datasets
  • Synthetic data generation
  • Healthcare data analytics

Where Syntegra is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Syntegra business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

  1. Synthetic Healthcare Data Solutions: Commercializing synthetic healthcare data solutions for AI model training and research purposes. As a seed-stage company, the specific revenue mechanics are not yet publicly disclosed.

Go-to-market motion1 record

Syntegra product offering

Product offering

Core offering

Syntegra applies state-of-the-art machine learning models to generate synthetic healthcare datasets that mirror the statistical properties of real-world patient data while preserving privacy and ensuring compliance with HIPAA, GDPR, and CCPA. The pre-trained synthetic data models are used for AI model training, medical research, drug discovery, and clinical trial design optimization, allowing healthcare organizations to develop and validate AI without accessing sensitive patient information.

Product overview

Syntegra offers healthcare data synthetic solutions powered by generative AI. The company provides a pre-trained model that generates synthetic healthcare data for research and AI development purposes. The core product enables organizations to create privacy-compliant artificial datasets while maintaining the statistical properties of original healthcare data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Healthcare Data Synthetic Solutions AI-powered synthetic data generation platform that creates privacy-preserving artificial healthcare datasets from real-world data, enabling research and AI development without exposing sensitive patient information. Designed for healthcare organizations, life sciences companies, and research institutions that need compliant training data for AI model development, drug discovery, and clinical trial design.

Quantifiable outcome

  • Synthetic healthcare data enables AI model training while maintaining HIPAA/GDPR compliance

Companies that use Syntegra

Customer profile

Segments1 record

Ideal customer profiles1 record

Syntegra technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

Syntegra partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Healthcare CollaboratorsdevelopingOthers · 12 January 2022Syntegra is building collaborations in healthcare, technology, and data privacy sectors. The seed funding will support growth in these collaborations, though specific named partners have not been disclosed.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Syntegra competitors and assessment

Company assessment

Direct peers

  • MDClone: MDClone generates synthetic healthcare data for research and analytics without exposing real patient records. Direct competitor to Syntegra in the privacy-preserving healthcare synthetic data space, serving similar hospital and life sciences customers.
  • Gretel.ai: Gretel provides a developer-focused synthetic data platform with APIs for generating synthetic text, tabular, and time-series data, including healthcare use cases. Direct competitor on synthetic data generation technology, though Gretel is horizontal rather than healthcare-specialized.
  • Tonic.ai: Tonic.ai offers synthetic data generation and de-identification primarily for software development and testing, with extensions into healthcare and regulated industries. Competes with Syntegra on synthetic data tooling, though Tonic's strongest footprint is in dev/test data rather than clinical research.
  • Mostly AI: Mostly AI provides a synthetic data platform for tabular data including financial services and healthcare. Direct competitor in synthetic data generation, with comparable privacy-preserving positioning to Syntegra but broader vertical reach.
  • Hazy: Hazy is an enterprise synthetic data platform focused on financial services with expanding healthcare applications. Competes with Syntegra on generative synthetic data technology, particularly for structured tabular datasets.

Broad incumbents

  • Datavant: Datavant is a large, well-capitalized health data connectivity platform that has expanded into de-identified and synthetic data offerings for healthcare and life sciences. Much broader portfolio than Syntegra, but overlaps directly on enabling privacy-preserving health data access.
  • AWS (HealthLake / Bedrock synthetic data): AWS provides HealthLake and Bedrock-based services that include capabilities relevant to healthcare data management and synthetic data generation at scale. As a hyperscaler, AWS represents both a potential partner and a bundling threat to standalone synthetic data vendors like Syntegra.
  • IQVIA: IQVIA is a large CRO and healthcare data analytics provider with proprietary de-identified and synthetic patient datasets used for clinical research and commercial analytics. Competes with Syntegra at the buyer level for synthetic data in life sciences R&D.

Emerging players

  • Synthesis AI: Synthesis AI focuses on synthetic data for computer vision, with less direct healthcare overlap. Adjacent competitor in the broader synthetic data ecosystem relevant to AI model training.
  • TripleBlind: TripleBlind offers privacy-preserving data collaboration tools for healthcare AI, including synthetic data and federated learning. Partially overlapping with Syntegra on privacy-preserving healthcare data for AI development.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

Syntegra social profiles

Digital presence

Syntegra financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Syntegra leadership team

Management profile

Number of profiles

Profiles4 records

Syntegra funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Syntegra M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syntegra

What does Syntegra do?

Syntegra applies state-of-the-art machine learning models to generate synthetic healthcare datasets that mirror the statistical properties of real-world patient data while preserving privacy and ensuring compliance with HIPAA, GDPR, and CCPA. The pre-trained synthetic data models are used for AI model training, medical research, drug discovery, and clinical trial design optimization, allowing healthcare organizations to develop and validate AI without accessing sensitive patient information.

When was Syntegra founded?

Syntegra was founded in 2019. It employs 1 to 10 people.

Where is Syntegra based?

Syntegra is headquartered in San Francisco, United States, in the North America region.

How does Syntegra make money?

One revenue line is on record: synthetic Healthcare Data Solutions.

Who are Syntegra's main competitors?

Direct peers on record are MDClone, Gretel.ai, Tonic.ai, Mostly AI and Hazy. Broad incumbents are Datavant, AWS (HealthLake / Bedrock synthetic data) and IQVIA. Emerging players are Synthesis AI and TripleBlind.

Does Syntegra have an API?

No public API is recorded for Syntegra.

What industry is Syntegra in?

Syntegra's product category is Synthetic Healthcare Data Platform. Its primary akta.pro industry code is HDAAALAA, Synthetic Data Generation Platforms, with a secondary code of HDAAALAL, Domain-Specific Training Data Solutions (e.g., medical, AV, geospatial). Its NAICS code is 54171 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WsjGenerative AI Makes Headway in HealthcareAbridge AI's generative AI tool will be rolled out at University of Pittsburgh Medical Center to help doctors reduce note-writing time. Other startups like Syntegra use generative AI to create realistic patient data for research, though accuracy concerns remain.GlobeNewswireSyntegra and Datavant Partner to Enable the Exchange of Synthetic Data Across the Healthcare SystemSyntegra and Datavant announced a partnership integrating Syntegra's synthetic data capabilities into Datavant Switchboard, enabling members to generate and exchange privacy-preserved synthetic healthcare data. The partnership uses Syntegra's generative AI to create high-fidelity datasets that protect patient privacy while matching statistical properties of real data.GlobeNewswireSyntegra and Datavant Partner to Enable the Exchange of Synthetic Data Across the Healthcare SystemSyntegra and Datavant announced a partnership integrating Syntegra's synthetic data capabilities into Datavant Switchboard, enabling members to generate and exchange privacy-preserved synthetic healthcare data. The partnership allows Datavant customers to use Syntegra's generative AI to create high-fidelity synthetic datasets that protect patient privacy while matching statistical properties of real data.PR NewswireSyntegra Pushes the Boundaries of Generative AI in Healthcare with Recent Tech UpdatesSyntegra announced the launch of Syntegra Medical Mind 2.0, an upgrade to its proprietary synthetic healthcare data engine that utilizes generative AI technology. The update features significant performance improvements, including training speeds three times faster and generation speeds twice as fast, while supporting datasets with over 20 million patient records. This release aims to accelerate AI/ML model development and data sharing in the healthcare sector by providing high-fidelity, privacy-compliant synthetic data.AtroposhealthSyntegra & Atropos Partner to Generate Evidence from Synthetic DataSyntegra and Atropos Health announced a partnership allowing Atropos's Green Button Informatics Consult and Evidence Platform to query Syntegra's privacy-preserving synthetic data alongside its existing real-world datasets. Syntegra will supply millions of synthetic patient records, with the initial phase focused on demonstrating clinical value. Financial terms were not disclosed.PR NewswireAtropos Health Partners with Syntegra to Broaden Access to Data-Driven Clinical CareAtropos Health and Syntegra announced a partnership to add Syntegra's privacy-preserving synthetic data to Atropos's Green Button informatics consult platform. The collaboration expands queryable data beyond real-world datasets, aiming to fill coverage gaps for underrepresented populations. The initial phase will demonstrate clinical value and provide millions of synthetic patient records.PR NewswireSyntegra and the Institute for Health Metrics Expand Strategic Partnership to Bring Privacy-Guaranteed Healthcare Data to Life SciencesSyntegra and the Institute for Health Metrics expanded their partnership to provide privacy-guaranteed synthetic electronic health records to life sciences companies. The data represents 7 million patients from U.S. health systems over five years, including social determinants of health. Pharma organizations can use it to improve real-world evidence and health economics of care studies.PR NewswireSyntegra Partners with InterGen Data to Provide a Safe Way of Leveraging Healthcare Records to Predict Life EventsSyntegra announced a partnership with InterGen Data to utilize synthetic healthcare records for predicting life events. This collaboration enables financial services, insurance, and home healthcare companies to analyze patient-level data without privacy risks or administrative barriers. The initiative aims to help institutions improve customer planning and wellbeing by bridging the gap between data utility and privacy requirements.TechCrunchEmpowering a new wave of health tech startups — with dataSyntegra and Tuva Health are releasing free synthetic healthcare datasets for health tech startups. The datasets are realistic but fake patient data, intended for building health tech applications. This move aims to democratize data analytics and privacy-preserving synthetic data in the sector.Pulse 2.0Syntegra Raises $5.625 Million In Seed FinancingSyntegra raised $5.625 million in seed funding from investors including Sweat Equity Ventures, Hike Ventures, and others. The capital will support commercializing synthetic healthcare data solutions and growing its Medical Mind model, which has trained on over 10 million records. The company has more than tripled its customer base in the past year.